Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 301-350 of 1329 result(s).
CYDY CytoDyn Inc
05/23/2025 12:21:40 PM
In one embodiment, the administrat (4)
CYDY CytoDyn Inc
05/22/2025 10:18:26 PM
Haha....& i just said on ST: 5 yr.. (2)
CYDY CytoDyn Inc
05/22/2025 9:30:40 PM
& look @ his vesting period 1st 250 (1)
CYDY CytoDyn Inc
05/22/2025 9:21:50 PM
Basket trial: CTCs secondary end po (1)
CYDY CytoDyn Inc
05/22/2025 2:36:06 AM
Like i've pointed out a patent dose (7)
CYDY CytoDyn Inc
05/20/2025 4:42:30 PM
LL has cleared metastatic prostate (2)
CYDY CytoDyn Inc
05/20/2025 1:44:08 PM
They're crossed misiu --- been 1 he (6)
CYDY CytoDyn Inc
05/20/2025 12:56:35 PM
2021: Outcome Measures: Correlation (1)
CYDY CytoDyn Inc
05/20/2025 12:21:25 PM
Measuring PD-L1 was a trial Measure (5)
CYDY CytoDyn Inc
05/19/2025 5:10:22 PM
Thx KC & mfg --- question: how do y (1)
CYDY CytoDyn Inc
05/19/2025 10:34:19 AM
Yes, the FDA has accepted PD-L1 as (15)
CYDY CytoDyn Inc
05/19/2025 5:38:42 AM
Looking it over from Feb. 11th -- n
CYDY CytoDyn Inc
05/19/2025 5:18:20 AM
Wooo...just found the post -- but w
CYDY CytoDyn Inc
05/19/2025 4:22:56 AM
Hahaa...just that NASDAQ can be put
CYDY CytoDyn Inc
05/19/2025 4:15:06 AM
If there's any drug to break the mo
CYDY CytoDyn Inc
05/19/2025 4:09:14 AM
Would like to see FDA path, state/f (2)
CYDY CytoDyn Inc
05/19/2025 3:51:16 AM
Someone posted inbetween this they (2)
CYDY CytoDyn Inc
05/19/2025 3:41:37 AM
Agree 100%. Have said the same sinc (2)
CYDY CytoDyn Inc
05/19/2025 12:59:29 AM
sherlock -- don't forget Long actin (2)
CYDY CytoDyn Inc
05/19/2025 12:17:56 AM
Inflammation "CCR5" mixed with a lo (1)
CYDY CytoDyn Inc
05/18/2025 11:18:33 PM
Yea...LL won't patent extend Keytru (3)
CYDY CytoDyn Inc
05/18/2025 10:42:14 PM
They'll switch to the LL side & wor (2)
CYDY CytoDyn Inc
05/18/2025 10:31:18 PM
Targeting PD-1/PD-L1, either alone (3)
CYDY CytoDyn Inc
05/18/2025 7:23:00 PM
Leronlimab goes out into the dark, (1)
CYDY CytoDyn Inc
05/18/2025 12:08:25 PM
Need clarity this week on where we (3)
CYDY CytoDyn Inc
05/18/2025 8:04:57 AM
Maybe this FDA table for surrogate (2)
CYDY CytoDyn Inc
05/18/2025 12:14:58 AM
Study: Long COVID ‘brain fog’ l (3)
CYDY CytoDyn Inc
05/17/2025 10:31:42 PM
Commissioner Makary continues to gi (3)
CYDY CytoDyn Inc
05/17/2025 7:34:08 PM
Accelerated approval. FDA may grant (12)
CYDY CytoDyn Inc
05/17/2025 7:31:31 PM
KC -- here's Tracies patent & when (1)
CYDY CytoDyn Inc
05/17/2025 6:37:17 PM
Nope...a much higher dosing is refe
CYDY CytoDyn Inc
05/17/2025 5:35:20 PM
Forgot to add on the CFO: "....with (1)
CYDY CytoDyn Inc
05/17/2025 5:28:03 PM
In a patent, around 1800mg is refer (1)
CYDY CytoDyn Inc
05/17/2025 5:26:32 PM
" not just congratulating them on t (1)
CYDY CytoDyn Inc
05/17/2025 4:56:09 PM
Place Blok's ESMO comments in sync: (4)
CYDY CytoDyn Inc
05/16/2025 11:01:40 AM
Post by thriving 4m @my69z The Marc (3)
CYDY CytoDyn Inc
05/16/2025 10:33:30 AM
Now we see why Creativ was so excit (2)
CYDY CytoDyn Inc
05/16/2025 9:02:02 AM
BTG on ST made an absolutely GREAT (4)
CYDY CytoDyn Inc
05/16/2025 6:51:24 AM
Forgot to add --- https://investors
CYDY CytoDyn Inc
05/16/2025 6:49:13 AM
Sounds like it should be -- Thx for (1)
CYDY CytoDyn Inc
05/16/2025 5:52:07 AM
Don't forget our Long Acting patent (3)
CYDY CytoDyn Inc
05/16/2025 2:45:12 AM
I kinda don't think ...late correct (1)
CYDY CytoDyn Inc
05/16/2025 2:09:01 AM
"...but that blows our entire budge (6)
CYDY CytoDyn Inc
05/15/2025 7:45:15 PM
For me, if our confirmation trials (6)
CYDY CytoDyn Inc
05/15/2025 4:00:56 PM
pembrolizumab=Keytruda OS=23 months (3)
CYDY CytoDyn Inc
05/15/2025 3:32:53 PM
Sbowers59 12:52 PM $CYDY Tyler bloc (8)
CYDY CytoDyn Inc
05/15/2025 2:05:20 AM
Can put developmental & all kinds o (2)
CYDY CytoDyn Inc
05/15/2025 1:38:51 AM
“Leronlimab’s ability to induce (2)
CYDY CytoDyn Inc
05/15/2025 1:36:04 AM
From past trial protocol: Outcome M (6)
CYDY CytoDyn Inc
05/14/2025 8:12:29 AM
Hiv resevoir -- that wholy grail -- (2)
Go to page:
  • << First
  • < Previous
  • 6
  • 7
  • Next >

Recent Articles

  • Altimmune, Inc. Faces Class Action: Investors Mobilize for Justice
  • Exciting Groundbreaking Ceremony for Toll Brothers New Community
  • Join the Fight: Altimmune, Inc. Class Action Insights
  • Mark Cuban's Warnings on TikTok's Potential New Ownership
  • SelectQuote, Inc. Class Action: Know Your Rights and Options
  • Tesla Investors Take Action: Class Action Lawsuit Explained
  • Investors Rallying for Justice in Unicycive Therapeutics
  • Huawei Elevates Intelligent Network Offerings to Fuel Industry Growth
  • Edimakor V4.4.0: A Game-Changer for Video Creation
  • Explore the Folger's Latest Exhibition on Shakespeare's Legacy
  • Growing HEOR Services Market Expected to Reach USD 8.5 Billion
  • Charter Communications Faces Class Action Lawsuit After Claims
  • Cyber A.I. Group Sets Path to Enhance Global Cybersecurity Reach
  • Fayetteville State University Enhances Nursing Program with Gift
  • Investigation Alert for CTO Realty Growth, Inc. Investors
  • Fayetteville State University Receives Major Boost for Nursing
  • Thermo Fisher Scientific Sees Positive Market Indicators
  • Understanding Market Trends for Sphere Entertainment Co.
  • Understanding the Impact of Short Interest on Cleanspark Inc.
  • Analyzing C.H. Robinson Worldwide Inc's Market Dynamics
  • Exciting Loyalty Rewards: McDonald's Monopoly Game Returns!
  • Masseto Introduces Its Latest 2022 Vintage with Elegance
  • Exciting New Opportunities for Space Research Funding
  • Michael Baker International Welcomes New Director for Bridges
  • Innovative AI Solutions to Strengthen Love Across Distances
  • AFA Welcomes New Leadership to Strengthen Air Power Advocacy
  • Dan Rootenberg Receives Prestigious Lifetime Achievement Award
  • University of Detroit Mercy Achieves Notable Ranking in Education
  • HMA Welcomes Libby Moore as New Chief People Officer
  • Ongoing Investigation Into Tandem Diabetes Care (TNDM) Raises Concerns
  • Marex Group plc Faces Ongoing Legal Scrutiny Over Finances
  • Aviatrix Joins Forces with Microsoft for Enhanced Security Solutions
  • Tyson Foods Faces Ongoing Beef Market Challenges Ahead
  • Aviatrix Enhances Microsoft Security Ecosystem with New Solutions
  • Critical Update for Fluor Corporation Investors Regarding Legal Action
  • Rehmann Launches Art Contest to Honor Red Wings' Legacy
  • Understanding Photronics Inc's Current Market Dynamics
  • Insight into Large Investors' Strategies with BLK
  • Stowers Institute Welcomes Esteemed Scientist David Stern
  • Insights into Palo Alto Networks' Options Market Actions
  • Exploring the Aging with the Experts Podcast by ALCA
  • Analyzing Chevron's Recent Options Movement for Insights
  • Urgent Appeal for Government Action to Support Veterans
  • Equity Union Commercial Facilitates $9.6 Million Multifamily Deal
  • Blue Cross Blue Shield Global Solutions: A New Era in Healthcare
  • Kawneer Unveils Innovative OptiQ® Window for Modern Spaces
  • AbbVie Expands Biologics Manufacturing with Major Investment
  • Ontinue Enhances Cybersecurity with Microsoft Partnership
  • DHS Investigation Reveals Abuse of Power in TSA Operations
  • Spirit Airlines Strengthens Operations Amid Restructuring Progress
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site